| 1 |
How might using gold nanoparticles in electrochemical sensors enhance early-stage disease detection?
|
2. By increasing surface interactions for more accurate biomarker capture |
|
Gold biosensors increases surface area and allows for more electron transfer rate because of more surface volume ratio. |
It enhance the electron transfer rates and provide active sites for biomolecule attachment, improving the sensor's performance |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following best explains how label-free electrochemical sensors support point-of-care medical diagnostics?
|
3. They provide direct measurement of target molecules with minimal preparation |
|
They do not require a lot of time which is excellent for point of care diagnostics, as patients will be able to get personalized care fast and accurate on site. |
The integration of electrochemical sensors into diagnostic devices has led to the development of point-of-care testing (POCT) systems which offer immediate results and can be used in a variety of settings including remote and resource-limited areas. This part of the article highlights how point of care testing is most common for remote areas, meaning supplies used should be effective and portable. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Why is electrochemical transduction considered advantageous over optical transduction in medical diagnostic sensors?
|
4. It uses radioactive tracing for enhanced stability |
|
It is easier to use as it only requires biological molecules, and little interpretation from light signals. Unlike optical sensors were there needs to be analysis of the molecule's refraction, reflection, and absorption of light. It is better as it provides more accurate results and is portable for remote care. |
This capability allows for the construction of smaller, more efficient sensors that require less sample volume and reagent, making them more practical for clinical and field applications. This shows how electrochemical transduction is better due to it's portability. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which action would most effectively increase specificity in a sensor designed to detect a single disease biomarker?
|
3. Functionalizing the electrode with disease-specific aptamers |
|
This way, only one type of biomarker/ pathogen can fuse with the sensor. |
Biosensors incorporate a biological recognition element such as enzymes, antibodies, or nucleic acids, that specifically interacts with the target analyte. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
In a scenario where a sensor must detect ultra-low concentrations of a cancer biomarker, which modification is most critical?
|
3. Incorporating nanostructures to increase surface-to-volume ratio |
|
By using nanostructure, there will be an increased in surface area, which gives more room for targets to bind, this decreases the detection limit. |
"Chen et al. developed an electrochemical platform based on nanoparticles functionalized with methylene blue-tagged DNA probes for ctDNA detection (Chen et al., 2021). Hybridization-induced electron transfer between MB and ferricyanide enabled ultra-low detection limits" through the use of nanotechnology Chen was able to use ultra-low detection limits. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Why might two electrochemical sensors using the same nanomaterial produce inconsistent results?
|
3. Variations in nanomaterial synthesis affect structural uniformity |
|
Material and form of the nanomaterial are very important in how results will turn out, that is why there are different methods for medical diagnosis. |
"Each method offers distinct advantages and can be chosen based on the specific requirements of the sensor application." this part of the text shows how it also is important to consider the factors of materials, and application. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
Which characteristic makes nanotechnology-based electrochemical sensors especially suitable for wearable medical devices?
|
3. They allow miniaturization without losing sensitivity |
|
Nanotechnology are extremely small and also has excellent sensitivity due to it's increased surface area to volume ratio. It is suitable for wearable devices because patients will be able to use them in everyday life. and give real-time accurate data. |
Portable and wearable devices improve patient compliance by offering non-invasive and convenient monitoring solutions. This highlights the advantages of nanotechnology in wearable sensors. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What would likely happen if the bioreceptor layer is poorly immobilized on the sensor surface?
|
3. Target biomolecules may not bind effectively, leading to weak or inaccurate signals |
|
There will be weak signals because the layers are not attached properly, when the signals are weak target biomolecules may not bind and so signals and results may be inaccurate and not reliable. |
"Combining different nanomaterials (e.g., graphene with metal nanoparticles) in a layer-by-layer fashion can synergistically improve the sensor's electrochemical properties." |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
Which modification would most directly enhance electron transfer in the sensor system?
|
2. Incorporating carbon nanotubes on the electrode surface |
|
Carbon nanotubes may act as a catalyst, and give out improve conductivity making particles move faster which enhances electron transfer. |
"Many nanomaterials, such as carbon nanotubes, graphene, and certain metal nanoparticles, exhibit excellent electrical conductivity. This property facilitates efficient electron transfer processe" |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
How can digital sensing technologies best support personalized cancer care?
|
2. By collecting real-time data on patient-specific symptoms and responses |
|
digital sensing technology allows personalized patient care in all settings. Being non-invasive, real-time monitoring, and can be done in remote areas. These benefits are significantly important as it can optimize patient care. |
real time monitoring is important because it allows patients and care givers to see the current situation of the diseases giving the best solution and treatment. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
If a clinician needs to monitor fatigue and motion in cancer patients at home, which device should be prioritized?
|
2. Smart accelerometers in wearables |
|
These wearables allow doctors to track patient's progress and recovery, giving a personalized treatment. This device would work best as it is wearable not affecting the patient much and still allows care givers to take care of patients remotely. |
smartphone accelerometers to track post-surgical recovery among cancer patients. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Why is combining sensor data with patient-reported outcomes (PROs) important in digital cancer care?
|
3. It allows a holistic understanding of patient experience |
|
It is important to understand, report and improve from patients experience, by using these methods it allows more insight into each case and how treatment can be imporved. |
It is used to improve cancer care, by understanding patient experience without having to do clinical trials. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
A hospital invested in wearable digital monitoring but received low engagement from patients. Which of the following is most likely a contributing factor?
|
3. Low digital health literacy among patients |
|
Patients may not be familiar of how to use the device and are still confused as it is not part of their daily life. |
As patients may be fatigued or have little digital knowledge, they may not be able to work out how to use the digitial monitoring devices. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
Which future trend is most aligned with the development of emerging digital cancer platforms?
|
2. Creation of pocket-sized biosensing tools integrated with smartphones |
|
With new technology, there has been attempts to create small portable biosensing tools to enhance treatment in rural areas or even make treatment more convinent and accurate. |
Detection for short periods of time may be unreliable so pocket sized tools are made to monitor patients throughout the day/life to give accurate results. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How can real-time symptom monitoring positively affect treatment decisions?
|
3. By enabling rapid intervention before major deterioration |
|
By having real-time detection it allows for faster treatment. |
Faster treatment will increase survival rates in most diseases, with real-time detection care givers are able to imedietntly act. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
Which technology is best suited to detect rare cancer biomarkers with high precision?
|
1. Digital ELISA |
|
As ELISA are for marking specific molecules and are highly sensitive, they are best for testing rare cancers. |
"Digital ELISA and digital flow cytometry, "digital" means the binary counting of individual molecules or particles, which allows for highly sensitive measurement based on distinct events" this allows for sensitive and accurate testing, which is suitable for rare cancers. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
Why is collaboration between data scientists and clinicians essential in digital oncology platforms?
|
3. Data insights require clinical validation for real-world use |
|
For safety and reliability reasons, these two occupations have to collaborate in order to give out the best product. In each their own fields data scientists can predict and create different tools that can benefit the healthcare system, but yet again without the actual knowledge from clinicians the results may be seen as inaccurate. |
"As digital biosensor technologies progress toward clinical adoption, robust validation through clinical trials is essential to establish their diagnostic reliability and regulatory approval." these two jobs have to work together to ensure reliable results for care. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
Which outcome is most likely when cancer patients actively use digital health tools to track their condition?
|
2. They engage more actively in shared treatment decisions |
|
It allows patients to be more involved in their treatment as they can see the process of their diagnosis. |
With more knowledge and information on their sickness patients may be more open to try treatments. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
A research team is developing a highly selective electrochemical sensor for detecting cancer biomarkers in blood. Based on the diagram, which combination of nanoparticle properties would most likely enhance both specificity and signal sensitivity?
|
2. Small spherical particles with antibody-conjugated targeting ligands |
|
The small spherical particle gives this small nano structure allowing more surface area and the antibody targeting ligands will allow for specific and accurate detection. |
small nanoparticles give more surface to volume ratio and having only antibody targeting allows specific biomarkers to attach. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
A hospital is planning to adopt a single digital sensing platform to support a wide range of diagnostic applications. Based on the image, which of the following most justifies this decision?
|
2. One platform can be customized to detect toxins, cancer biomarkers, and heavy metals using interchangeable biorecognition elements |
|
Multiplex, giving lots of features to one device |
there are multiple biomarkers to detect on this sensor |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|